Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: all 137 studies
Page 2 of 2. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- Biomarkers in PolyradiculoneuropathiesStatus unknownNCT04249752
- Posturography-NeuropathyCompletedNCT04154540Not applicable
- Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT03967899
- The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 AutoantibodiesCompletedNCT03864185Phase 2
- Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate AnticoagulationStatus unknownNCT03801135Not applicable
- Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDPTerminatedNCT03779828
- Clinical Trial to Assess the Safety of a Novel Scaffold BiomaterialActive, not recruitingNCT03584022Not applicable
- Diffusion Tensor Imaging in Chronic Inflammatory Demyelinating Polyneuropathy (PIDC)CompletedNCT03460951
- Quantification of Nerve Stiffness in NeuropathiesCompletedNCT03397303Not applicable
- Panzyga in CIDP Administered at Different Infusion RatesStatus unknownNCT03166527Phase 3
- Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAGCompletedNCT03008733Not applicable
- Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous ImmunoglobulinCompletedNCT02892890Not applicable
- Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT02629796
- Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating NeuropathyWithdrawnNCT02574962Phase 2
- IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength MeasurementsCompletedNCT02414490
- Transcriptome Analysis of the Peripheral Blood in CIDPStatus unknownNCT02404298Not applicable
- IVIg for Demyelination in Diabetes MellitusStatus unknownNCT02372149Phase 4
- sCD163 & CD19 as Candidate Biomarkers in CIDP and MMNStatus unknownNCT02271724
- Effect of Resistance and Aerobic Exercise in CIDP or MMNCompletedNCT02121678Not applicable
- Immunoglobulin Dosage and Administration Form in CIDP and MMNCompletedNCT02111590
- MRI in Diagnosing and Monitoring CIDPCompletedNCT02017769
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Magnetic Resonance Diagnostics of Diabetic Peripheral NeuropathyCompletedNCT01847937
- Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.CompletedNCT01824251Phase 3
- Change of Nerve Conduction Properties in IVIg Dependent NeuropathiesStatus unknownNCT01655394
- Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT01379833
- Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIgCompletedNCT01349270Phase 3
- High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating PolyneuropathyWithdrawnNCT01236456Phase 2
- Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDPTerminatedNCT01225276Phase 2/3
- Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT01017159Phase 2
- Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesActive, not recruitingNCT00716066Phase 2
- Study of CIDP Patients During IVIG TreatmentCompletedNCT00305266
- Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT00099489Phase 2
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating PolyneuropathyCompletedNCT00004939Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00004772Phase 3
- Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating NeuropathyCompletedNCT00004286Phase 3
- Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00001287Phase 2
← Polyradiculoneuropathy, Chronic Inflammatory Demyelinating overview